Reference : Assessing the role of polygenic background on the penetrance of monogenic forms in Pa...
E-prints/Working papers : Already available on another site
Human health sciences : Oncology
Systems Biomedicine
http://hdl.handle.net/10993/47448
Assessing the role of polygenic background on the penetrance of monogenic forms in Parkinson\textquoterights disease. 2021.06.06.21253270
English
Hassanin, Emadeldin [> >]
May, Patrick mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core]
Aldisi, Rana [> >]
Krawitz, Peter [> >]
Maj, Carlo [> >]
Bobbili, Dheeraj Reddy mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core]
6-Jun-2021
Cold Spring Harbor Laboratory Press
No
[en] Parkinson's disease ; Polygenic risk ; monogenic disease
[en] Background: Several rare and common variants are associated with Parkinson's disease. However, there is still an incomplete penetrance in the carriers of rare variants associated with Parkinson's disease. To address this issue, we investigated whether a PRS calculated from significant GWAS SNPs affects the penetrance of Parkinson's disease among carriers of rare monogenic variants in known Parkinson's disease genes and those with a family history. Methods: We calculated the PRS based on common variants and selected the carriers of rare monogenic variants by using the exome data from UK Biobank. Individuals were divided into three risk categories based on PRS: low (<10%), intermediate (10%-90%), and high (>90%) risk groups. We then compared how PRS affects Parkinson\textquoterights disease risk among carriers of rare monogenic variants and those with family-history. Results: We observed a two-fold higher odds ratio for a carrier of a monogenic variant that had a high PRS (OR 4.07,95\% CI, 1.72-8.08) compared to carriers with a low PRS (OR 1.91, 95\% CI, 0.31-6.05). In the same line, carriers with a first-degree family history and with \>90\% PRS have even a higher risk of developing PD (OR 23.53, 95\%CI 5.39-71.54) compared to those with \<90\% PRS (OR 9.54, 95\% CI 3.32-21.65). Conclusions: Our results show that PRS, carrier status, and family history contribute independently and additively to the Parkinson's disease risk.
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
The FNR supported P.M. as part of the National Centre of Excellence in Research on Parkinson's disease (NCER-PD, FNR11264123) and the DFG Research Units FOR2715 (INTER/DFG/17/11583046) and FOR2488 (INTER/DFG/19/14429377)
Researchers ; Professionals
http://hdl.handle.net/10993/47448
10.1101/2021.06.06.21253270
https://www.medrxiv.org/content/early/2021/06/09/2021.06.06.21253270
https://www.medrxiv.org/content/10.1101/2021.06.06.21253270v1
FnR ; FNR14429377 > Anne Grünewald > ProtectMove II > Reduced Penetrance In Hereditary Movement Disorders: Elucidating Mechanisms Of Endogenous Disease Protection > 01/07/2020 > > 2020

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
2021.06.06.21253270v1.full.pdfPublisher postprint389.27 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.